Compare Enzyme (MLN) vs Viction (VIC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enzyme vs Viction — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Viction trades at Rp705.82 (market cap Rp89,72M, Rp28,07M 24h volume). The key difference: Enzyme is the larger of the two by market cap, and Viction's supply is capped (127,3M / 210M VIC (61%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 28 Days and Viction for 38 Days on average.
| MLN | VIC | |
|---|---|---|
Market Cap | Rp134,13M | Rp89,72M |
Volume (24h) | Rp104,56M | Rp28,07M |
Circulating Supply | 3,3M MLN | 127,3M / 210M VIC (61%) |
Typical Hold Time | 28 Days | 38 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.
Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.
Viction (VIC) is currently trading at Rp706.03 with a bearish technical outlook, as indicated by moving averages, while oscillators remain neutral. The price hovers near the pivot point of Rp705, with immediate support at Rp673 and resistance at Rp732. No major protocol updates or ecosystem developments have been reported recently, and the circulating supply stands at 61% of the maximum 210 million tokens.
Overall outlook is cautious due to bearish technical signals and lack of recent fundamental catalysts. Key opportunities include potential rebounds from support levels, while major risks involve low liquidity and high volatility typical of smaller market cap cryptocurrencies. Investors should monitor for any upcoming network updates or shifts in market sentiment.
About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →About Viction
Viction, formerly TomoChain, is a people-centric layer-1 blockchain offering zero-gas transactions and enhanced security to make Web3 easy and safe for everyone. Designed with a focus on user experience, Viction prioritizes zero-gas transactions, speed, security, and scalability to create a more secure and open world. Viction is driven by a mission to build a decentralized platform that empowers humanity to connect, collaborate, and create without limitations, envisioning a world where transparency, accessibility, and growth thrive.
Read more on VIC →
